Enovis Corporation

NYSE:ENOV

Medical - Devices

Healthcare
$27.10 +3.50%

+$0.73 today

Market cap
$1.56B
Beta
1.49
P/E (TTM)
-1.1
EPS (TTM)
-$20.02
52W Low $20.55High $36.82

Volume 0.88M

Average 0.99M

ENOV Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Enovis CorporationNYSE: ENOV

Depreciation & Amortization · Q1 FY2026 · quarter ended Apr 2026

Depreciation & amortization grows, but more slowly than its trailing trend

Q1 FY2026 depreciation & amortization of $73.36M rose 2.7% year over year, behind the +4.8% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 4.7% from the prior quarter. Over 3 fiscal years it compounded at +10.2% a year.

Context

  • Depreciation & amortization amounted to 13.1% of revenue in FY2025, down 0.4 pp from a year earlier.
  • Depreciation & amortization increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +2.7% toward the trailing-twelve-month pace of +4.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
$73.36M-4.7% QoQ
Last fiscal yearDec 2025
$294.38M+3.4% YoY
LTMApr 2026
$296.3M+4.8% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.7%——
1 year+3.4%——
3-year CAGR+10.2%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
294.38M USD
Year-over-year change
+3.4%
4-year CAGR
+2.9%

Depreciation & Amortization vs competitors

How ENOV compares with its peers on the latest reported figures

  • ENOV's LTM Apr 2026 depreciation & amortization of $296.3M is the highest of the 16 companies compared; the peer median is $57.33M.
  • Its year-over-year change of +4.8% is the 9th highest of 16, against a peer median of +6.0%.
  • Depreciation & amortization amounts to 13.0% of revenue for ENOV, versus a peer median of 3.2%.
ENOV Competitors Peer median
Depreciation & Amortization for ENOV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ENOVEnovis CorporationLTM Apr 2026$296.3M +4.8%+10.2%13.0%
ITTITT Inc.LTM Jul 2026$220.1M +52.8%+10.1%4.6%
IEXIDEX CorporationLTM Jun 2026$212.7M +8.8%+19.9%5.9%
NPOEnPro Industries, Inc.LTM Jun 2026$107M +6.0%-0.1%8.7%
MIDDThe Middleby CorporationLTM Jul 2026$92.2M -24.0%-8.6%2.6%
FELEFranklin Electric Co., Inc.LTM Sep 2026$69.73M +15.2%+7.7%3.1%
HLIOHelios Technologies, Inc.LTM Jul 2026$61.4M -4.1%+6.9%6.9%
WTSWatts Water Technologies, Inc.LTM Jun 2026$61.3M +9.7%+12.7%2.3%
KAIKadant Inc.LTM Jul 2026$57.33M +14.8%+13.6%5.0%
GRCThe Gorman-Rupp CompanyLTM Jun 2026$27.76M +0.0%+9.4%4.0%
EPACEnerpac Tool Group Corp.LTM Feb 2026$17.47M +29.4%-7.2%2.8%
LXFRLuxfer Holdings PLCLTM Mar 2026$12.4M -6.8%-10.7%3.3%
GHMGraham CorporationLTM Mar 2026$7.84M +32.1%+9.4%3.2%
HURCHurco Companies, Inc.LTM Apr 2026$2.42M -22.0%-11.8%1.3%
OFLXOmega Flex, Inc.LTM Mar 2026$1.36M +4.2%+7.5%1.4%
DCIDonaldson Company, Inc.LTM Jul 2026$0 -100.0%—0.0%
Peer median (excluding ENOV) $57.33M+6.0%+7.6%3.2%

Competitors are the stored peer set for ENOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.43B1.56B1.71B2.11B2.25B
Cost of Revenue648.51M693.72M716.42M926.87M902.79M
Gross Profit777.68M869.38M990.78M1.18B1.35B
Gross Margin54.5%55.6%58.0%56.0%59.8%
Research & Development49.09M60.83M75.33M91.3M120.33M
Selling, General & Admin665.78M772.91M830.31M939.36M1.07B
Operating Expenses840.47M940.56M1.06B1.96B1.36B
Depreciation & Amortization262.92M219.71M217.11M284.8M294.38M
EBITDA170.25M241.69M169.73M(481.03M)(830.22M)
EBITDA Margin11.9%15.5%9.9%-22.8%-36.9%
Operating Income(62.8M)(71.18M)(65.71M)(775.72M)(18.87M)
Operating Margin-4.4%-4.6%-3.8%-36.8%-0.8%
Interest Income0200K000
Interest Expense29.11M24.95M19.75M57.1M34.82M
Other Income / Expenses(58.98M)69.11M(1.42M)(47.21M)(1.14B)
Income Before Tax(121.78M)(2.07M)(67.13M)(822.92M)(1.16B)
Pre-Tax Margin-8.5%-0.1%-3.9%-39.0%-51.6%
Income Tax Expense(19.53M)36.12M(13.29M)4.49M22.29M
Net Income71.66M(13.29M)(33.26M)(825.49M)(1.18B)
Net Margin5.0%-0.9%-1.9%-39.2%-52.7%
EPS (Basic)(2.02)(0.28)(0.61)(14.93)(20.86)
EPS (Diluted)(2.02)(0.28)(0.61)(14.93)(20.86)
Weighted Avg Shares51.14M54.07M54.53M55.28M56.79M
Weighted Avg Shares (Diluted)51.14M54.07M54.49M55.28M56.79M

Enovis Corporation

NYSE:ENOV

Intrinsic Alpha fair value

Locked

Current Price

$27.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.